Drug firm Indoco Remedies on Monday said it has received approval from the US health regulator for blood thinning drug Apixaban tablets. In a regulatory filing, Indoco Remedies said it has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Apixaban tablets in the strengths of 2.5 mg and 5 mg. Apixaban is an anticoagulant, or blood thinner.